10-Q: Astrotech Corporation Reports Q3 2024 Results, Revenue Up 42.9% Year-Over-Year

Astrotech Corporation's Q3 2024 results show a revenue increase of 42.9% compared to the same period last year, driven by growth in maintenance and consumable sales.

Summary

• Astrotech Corporation reported a net loss of $3.154 million for the quarter ended March 31, 2024, compared to a net loss of $2.375 million for the same period in 2023.
• Revenue for the quarter increased to $50 thousand, up from $35 thousand in the prior year, primarily due to increased maintenance and consumable revenue.
• The company's gross profit was $8 thousand, with a gross margin of 16%, down from 31% in the same quarter of the previous year due to inflationary pressures on shipping.
• Operating expenses increased to $3.541 million, up from $2.761 million, driven by higher selling, general, and administrative costs, as well as increased research and development spending.
• For the nine months ended March 31, 2024, the company's net loss was $8.707 million, compared to $7.322 million in the same period of 2023.
• Revenue for the nine-month period was $1.590 million, up from $336 thousand in the prior year, due to new unit sales of the TRACER 1000.
• The company's gross margin for the nine-month period was 45%, up from 37% in the same period of the previous year due to design improvements and a comparative increase in sales price.
• Operating expenses for the nine-month period increased to $10.659 million, up from $8.453 million, due to increased selling, general, and administrative expenses, as well as higher research and development costs.
• As of March 31, 2024, Astrotech had cash and cash equivalents of $8.487 million and working capital of approximately $35.1 million.

Sentiment

Score: 4

Explanation: The document shows a mixed picture with revenue growth but also increased losses and operating expenses. The company is facing challenges in the supply chain and is still in the development and certification phase for some of its products. The sentiment is cautiously negative due to the increased losses.

Positives

• Revenue increased by 42.9% in Q3 2024 compared to the same quarter in 2023.
• Revenue for the nine months ended March 31, 2024, increased significantly compared to the same period in 2023.
• Gross margin for the nine-month period increased to 45%, up from 37% in the same period of the previous year.
• The company has deployed the TRACER 1000 in approximately 30 locations in 14 countries throughout Europe and Asia.
• The TRACER 1000 has been listed in the U.S. General Services Administration (GSA) IT Schedule 70.

Negatives

• The company experienced a net loss of $3.154 million in Q3 2024, which is higher than the $2.375 million loss in Q3 2023.
• Gross margin decreased to 16% in Q3 2024, down from 31% in Q3 2023.
• Operating expenses increased by 28.3% in Q3 2024 compared to the same period in 2023.
• The net loss for the nine months ended March 31, 2024, was $8.707 million, compared to $7.322 million in the same period of 2023.
• Cash and cash equivalents decreased by $5.721 million during the nine months ended March 31, 2024.

Risks

• The company is subject to various lawsuits and other claims in the normal course of business.
• The company's business is subject to the adverse impact of recent inflationary pressures, including significant increases in fuel costs.
• The company's business is subject to global economic conditions and events, including the ongoing wars in Ukraine and the Middle East and the COVID-19 pandemic.
• The company faces risks related to product demand and market acceptance, including the ability to develop and sell products to governmental or commercial customers.
• The company is subject to risks related to the availability of, and cost inflation in, supply chain inputs.
• The company faces uncertainty in government funding and support for key programs, grant opportunities, or procurements.
• The company is subject to the impact of competition on its ability to win new contracts.
• The company faces risks related to meeting technological development milestones and overcoming development challenges.
• The company may be detrimentally affected by a change in enforcement by federal or state governments regarding cannabis and cannabis products.

Future Outlook

The company continues to manage production, secure alternative supplies, and take other proactive actions to mitigate the impact of supply chain shortages and inflation. The company believes that it will be able to pass the inflation caused by raw materials shortages and increased shipping costs to its customers by increasing the price of its instruments. The long-term impact of the COVID-19 pandemic on the company's business may not be fully reflected until future periods.

Management Comments

• Management believes the AgLAB 1000-D2 will deliver a compelling combination of cost and time savings while enhancing product quality and quantity for distillation processors of hemp and cannabis.
• Management believes the AMS Technology provides a significant competitive advantage due to its small size, rugged design, quick analysis, and ease of use.
• Management believes that new tools to more quickly identify an infection may be present remain of the utmost importance in the battle against COVID-19 and other diseases.

Industry Context

The company operates in the mass spectrometry, security, agriculture, and breath analysis industries. The company's technology is positioned to compete with traditional methods in these sectors, offering advantages in cost, size, and ease of use. The company is working to gain certifications and approvals to expand its market reach.

Comparison to Industry Standards

• The company's TRACER 1000 competes with ion mobility spectrometry (IMS)-based explosives trace detectors (ETDs) used in airports and other security facilities. The company claims its technology has a virtually unlimited and easily expandable threat library, unlike IMS-based ETDs.
• AgLAB's mass spectrometers compete with high-performance liquid chromatography technology used in the hemp and cannabis markets. The company believes its technology has competitive advantages over the incumbent technology.
• The company's BreathTech division is developing a breath analysis tool to screen for VOC metabolites, which is a novel approach compared to traditional diagnostic methods.

Corporate Governance

Legal Proceedings

• The Company is not subject to any litigation at the present time.

Stakeholder Impact

• Shareholders may be concerned about the increased net losses and decreased gross margin in the short term.
• Employees may be impacted by the company's efforts to manage costs and improve efficiency.
• Customers may benefit from the company's innovative products and services.
• Suppliers may be impacted by the company's efforts to manage supply chain issues and inflation.
• Creditors may be impacted by the company's financial performance and liquidity.

Next Steps

• The company will continue to work with the TSA towards air cargo certification for the TRACER 1000.
• The company will continue to develop and market the AgLAB 1000 series of mass spectrometers for the hemp and cannabis markets.
• The company will continue to develop the BreathTest-1000 for breath analysis applications.
• The company will continue to market the Pro-Control Maximum Value Processing and the Pro-Control-1000 mass spectrometer for chemical manufacturing process control applications.

Key Dates

Keywords

mass spectrometry, explosives detection, narcotics detection, security, agriculture, breath analysis, chemical manufacturing, TRACER 1000, AgLAB, BreathTech, Pro-Control, TSA, ECAC, GSA